Merck Profile

69.06
USD 0.21  0.30%
100%
67%

Merck exotic insider transaction detected

Merck Co insider trading alert for general transaction of common stock - 401(k) plan by Anstice David W, Exec.V-P Strategy Initiatives, on August 19, 2018. This event was filed by Merck Co Inc with SEC on 2007-03-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Merck Summary

Being in one of the most regulated sectors, Merck is one of the names in big pharma and distributes many different types of medications and drugs. This industry is a go big or go home industry as that research and development costs large sums of money to complete, and if they drug does not get FDA approval, all of that work was for not. Also, it is important to keep an eye on the medical marijuana market as this is a direct threat to companies that produce medications. [more]
Merck Co (MRK) is traded on New York Stock Exchange in USA. It is located in 2000 Galloping Hill Road and employs 69,000 people. The company currently falls under 'Mega-Cap' category with total capitalization of 183.11 B. Merck Co runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 2.66 B outstanding shares of which 17.58 M shares are now shorted by investors with about 1.75 days to cover shorted positions. MERCK CO INC has about 7.35 B in cash with 6.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73.
Check Merck Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 69.06HorizonTargetOdds Above 69.06
97.32%30 days 69.06 2.62%
Based on normal probability distribution, the odds of Merck to move above current price in 30 days from now is roughly 2.62% (This Merck Co probability density function shows the probability of Merck Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares201.9 M12.3 B
Blackrock IncCommon Shares185.5 M11.3 B
View Merck Diagnostics

Selected Merck Co Income Statement Over Time

Earning Before Interest and Taxes EBIT    Net Income    Net Income Common Stock    

Key Fundamentals

Merck Against Markets

Risk Adjusted
Performance Score (0 to 100)
31 
Chance of
Financial Distress (0 to 100%)
8 
Equity ratings for Merck Co are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
It operates in four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 69000 people. more
NameMerck Co
Chairman, CEO and PresKenneth FrazierView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address2000 Galloping Hill Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number0000310158
ISINUS58933Y1055
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.merck.com
Phone908 740 4000
CurrencyUSD - US Dollar

Directors

Merck Corporate Directors
Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director
Please see also Stocks Correlation. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.